Factors Associated With Alzheimer's Dementia Diagnosis and Survival in Down Syndrome.
Olivia Pounds, Kate Theodore, Karen Dodd
PMID 40077827WHAT IT FOUND
Earlier baseline assessments and living with family predicted earlier dementia diagnosis in Down syndrome.
Median survival post-diagnosis was 4 years, with older age, epilepsy, and hospital residence linked to shorter survival. Anti-dementia medication showed no significant survival benefit.
Key findings
01Age at first assessment strongly predicted age at dementia diagnosis; living with family at diagnosis also predicted earlier diagnosis.
02Median survival after diagnosis was 4 years; later age at diagnosis, epilepsy, and living in hospital significantly increased hazard for death.
03Anti-dementia medication was not associated with significantly longer disease duration, though missing data limits this conclusion.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Considerable missing data (over 30%) for family history, anti-dementia medication, and intellectual disability severity limits interpretation. Ethnicity was not routinely collected, affecting representativeness and generalisability. APOE genotype could not be controlled for, which is a known predictor of dementia age and mortality in Down syndrome. The study included data from earlier periods that predate current best-practice guidance, potentially biasing results. Anti-dementia medications were not developed until later in the study period, limiting assessment of their effect. Intellectual disability severity was calculated using IQ cut-offs rather than adaptive functioning measures, which may be arbitrary.
Declared interests
The authors declare no conflicts of interest.
The easy way to misread this
Do not interpret the lack of significant effect for anti-dementia medication as proof of inefficacy, as over 55% of data for this variable was missing due to medications not being available during earlier study periods. Also, do not assume that living with family causes longer survival; it may reflect that family carers detect decline earlier, leading to diagnosis at a stage where more care options remain.